跳至主要内容
临床试验/CTRI/2024/03/063740
CTRI/2024/03/063740尚未招募4 期

Comparison of effectivity and adverse effects of two different doses of melatonin with zolpidem on insomnia in cancer patients: A prospective, comparative, interventional study

未提供1 个研究点 分布在 1 个国家目标入组 108 人开始时间: 2024年3月15日最近更新:

试验速览

阶段
4 期
状态
尚未招募
入组人数
108
试验地点
1
主要终点
Change in Pittsburgh sleep quality index score

研究概览

简要总结

Cancer patients with insomnia are identified with PSQI score > 5  HADS also measured at bseline. patients are randomized into 3 groups getting melatonin 3mg , melatonin 5mg, and zolpidem 5mg and assessed at 2 weeks, 4 weeks and 6 weeks PSQI and HADS measured

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
None

入排标准

年龄范围
20.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • Age between 20 and 65 years Registered in Palliative Medicine Department Suffering from a histologically diagnosed cancer Patients with sleep disturbance with a score 5 or higher on Pittsburgh sleep quality index (PSQI) Patient giving written informed consent for this study Patient having adequate pain relief and no history of dyspnoea.

排除标准

  • Patients with previous psychiatric disorder Patients on any sedatives/ hypnotics Patients in anti-anxiety medications Patient on anti-psychiatric treatment Patient having language and communication difficulties Patients using any kind of sleeping aids Having used melatonin for last one month Pregnant and lactating women Patients having severe liver and renal dysfunction Â.

结局指标

主要结局

Change in Pittsburgh sleep quality index score

时间窗: baseline,2,4 and 6 weeks

次要结局

  • Change in Hospital Anxiety Depression Score

研究者

发起方
未提供
责任方
Principal Investigator
主要研究者

SREEHARSH S

SAWAI MAN SINGH MEDICAL COLLEGE AND ATTACHED HOSPITAL JAIPUR

研究点 (1)

Loading locations...

相似试验